These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30472113)

  • 41. A role for cortical dopamine in the paradoxical calming effects of psychostimulants.
    Harris SS; Green SM; Kumar M; Urs NM
    Sci Rep; 2022 Feb; 12(1):3129. PubMed ID: 35210489
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic exposure to ethanol of male mice before mating produces attention deficit hyperactivity disorder-like phenotype along with epigenetic dysregulation of dopamine transporter expression in mouse offspring.
    Kim P; Choi CS; Park JH; Joo SH; Kim SY; Ko HM; Kim KC; Jeon SJ; Park SH; Han SH; Ryu JH; Cheong JH; Han JY; Ko KN; Shin CY
    J Neurosci Res; 2014 May; 92(5):658-70. PubMed ID: 24510599
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Altering the development of the dopaminergic system through social play in rats: Implications for anxiety, depression, hyperactivity, and compulsivity.
    Parvopassu A; Oggiano M; Festucci F; Curcio G; Alleva E; Adriani W
    Neurosci Lett; 2021 Aug; 760():136090. PubMed ID: 34197903
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novelty seeking and stereotypic activation of behavior in mice with disruption of the Dat1 gene.
    Pogorelov VM; Rodriguiz RM; Insco ML; Caron MG; Wetsel WC
    Neuropsychopharmacology; 2005 Oct; 30(10):1818-31. PubMed ID: 15856082
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
    Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
    Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacological characterization of the norepinephrine and dopamine reuptake inhibitor EB-1020: implications for treatment of attention-deficit hyperactivity disorder.
    Bymaster FP; Golembiowska K; Kowalska M; Choi YK; Tarazi FI
    Synapse; 2012 Jun; 66(6):522-32. PubMed ID: 22298359
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Individual differences in response to novelty predict prefrontal cortex dopamine transporter function and cell surface expression.
    Zhu J; Bardo MT; Bruntz RC; Stairs DJ; Dwoskin LP
    Eur J Neurosci; 2007 Aug; 26(3):717-28. PubMed ID: 17651428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Neuronal development of the hyperdopaminergic animal model].
    Kasahara Y; Arime Y; Kubo Y; Fukui A; Sora I
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Nov; 31(5-6):195-9. PubMed ID: 22256607
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Altered reward circuitry in the norepinephrine transporter knockout mouse.
    Gallagher JJ; Zhang X; Hall FS; Uhl GR; Bearer EL; Jacobs RE
    PLoS One; 2013; 8(3):e57597. PubMed ID: 23469209
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Behavioral and pharmacological characteristics of mice lacking the dopamine transporter].
    Biala G
    Postepy Hig Med Dosw (Online); 2004; 58():560-4. PubMed ID: 15765018
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT6 partial agonist in rats.
    Jastrzębska-Więsek M; Siwek A; Partyka A; Antkiewicz-Michaluk L; Michaluk J; Romańska I; Kołaczkowski M; Wesołowska A
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):839-49. PubMed ID: 27106213
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Influence of the
    Shumakova AA; Apryatin SA; Shipelin VA; Efimova EV; Fesenko ZS; Gmoshinski IV
    Vopr Pitan; 2020; 89(5):17-27. PubMed ID: 33211914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration.
    Young JW; Goey AK; Minassian A; Perry W; Paulus MP; Geyer MA
    Pharmacol Biochem Behav; 2010 Jul; 96(1):7-15. PubMed ID: 20363246
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of Tyrosine Hydroxylase Expression and Phosphorylation in Dopamine Transporter-Deficient Mice.
    Salvatore MF; Calipari ES; Jones SR
    ACS Chem Neurosci; 2016 Jul; 7(7):941-51. PubMed ID: 27124386
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased impulsive behavior and risk proneness following lentivirus-mediated dopamine transporter over-expression in rats' nucleus accumbens.
    Adriani W; Boyer F; Gioiosa L; Macrì S; Dreyer JL; Laviola G
    Neuroscience; 2009 Mar; 159(1):47-58. PubMed ID: 19135135
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Traumatic stress causes distinctive effects on fear circuit catecholamines and the fear extinction profile in a rodent model of posttraumatic stress disorder.
    Lin CC; Tung CS; Lin PH; Huang CL; Liu YP
    Eur Neuropsychopharmacol; 2016 Sep; 26(9):1484-1495. PubMed ID: 27492886
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deficit in working memory and abnormal behavioral tactics in dopamine transporter knockout rats during training in the 8-arm maze.
    Kurzina NP; Aristova IY; Volnova AB; Gainetdinov RR
    Behav Brain Res; 2020 Jul; 390():112642. PubMed ID: 32428629
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hyperdopaminergia and NMDA receptor hypofunction disrupt neural phase signaling.
    Dzirasa K; Ramsey AJ; Takahashi DY; Stapleton J; Potes JM; Williams JK; Gainetdinov RR; Sameshima K; Caron MG; Nicolelis MA
    J Neurosci; 2009 Jun; 29(25):8215-24. PubMed ID: 19553461
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A murine model of hyperdopaminergic state displays altered respiratory control.
    Vincent SG; Waddell AE; Caron MG; Walker JK; Fisher JT
    FASEB J; 2007 May; 21(7):1463-71. PubMed ID: 17255472
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference.
    Sora I; Hall FS; Andrews AM; Itokawa M; Li XF; Wei HB; Wichems C; Lesch KP; Murphy DL; Uhl GR
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5300-5. PubMed ID: 11320258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.